Anti-diabetic drugs of the thiazolidinedione (TZD) structural class as well as α-lipoic acid activate peroxisome proliferator-activated receptor γ (PPARγ), a nuclear transcription factor that controls glucose metabolism and lipid homeostasis. CAY10506 is a hybrid lipoic acid-TZD derivative that transactivates human PPARγ with an EC50 value of 10 µM.1
1
Chittiboyina, A.G., Venkatraman, M.S., Mizuno, C.S., et al. Design and synthesis of the first generation of dithiolane thiazolidinedione- and phenylacetic acid-based PPARγ agonists. J Med Chem494072-4084(2006).
Room temperature
in continental US; may vary elsewhere
SMILES
Copy SMILES to clipboard
O=C(CCCCC1SSCC1)NCCOc1ccc(cc1)CC1SC(=O)NC1=O
Background Reading
Chittiboyina, A.G., Venkatraman, M.S., Mizuno, C.S., et al. Design and synthesis of the first generation of dithiolane thiazolidinedione- and phenylacetic acid-based PPARγ agonists. J Med Chem494072-4084(2006).
Size
Price
Quantity
Subtotal
1 mg
$35.00
$0.00
5 mg
$158.00
$0.00
10 mg
$280.00
$0.00
50 mg
$1,225.00
$0.00
Bulk
Contact
Cart Total
$0.00
This product is available in custom sizes and/or larger quantities.